Showing results (971-980 of 994) with videos related to
Sort By:
Pageof 100
Science Translational Medicine|April 5, 2019
Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosisCharles R Esther, Marianne S Muhlebach, Camille Ehre, et al.European Journal of Human Genetics : EJHG|July 4, 2024
Burden re-analysis of neurodevelopmental disorder cohorts for prioritization of candidate genesNoor Smal, Fatma Majdoub, Katrien Janssens, et al.Journal of Clinical Microbiology|November 1, 2016
Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS IIIScott R Evans, Andrea M Hujer, Hongyu Jiang, et al.Genome Announcements|June 20, 2015
Genome Sequence of Mycobacteriophage MomoWelkin H Pope, Elizabeth A Bina, Indraneel S Brahme, et al.Journal of Medicinal Chemistry|August 13, 2013
Structure- and reactivity-based development of covalent inhibitors of the activating and gatekeeper mutant forms of the epidermal growth factor receptor (EGFR)Richard A Ward, Mark J Anderton, Susan Ashton, et al.American Journal of Respiratory and Critical Care Medicine|November 26, 2019
Airway Mucus Hyperconcentration in Non-Cystic Fibrosis BronchiectasisKathryn A Ramsey, Alice C H Chen, Giorgia Radicioni, et al.Science Advances|April 1, 2022
Mucus concentration-dependent biophysical abnormalities unify submucosal gland and superficial airway dysfunction in cystic fibrosisTakafumi Kato, Giorgia Radicioni, Micah J Papanikolas, et al.Journal of Medicinal Chemistry|March 22, 2007
Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinaseAndrew A Mortlock, Kevin M Foote, Nicola M Heron, et al.American Journal of Respiratory Cell and Molecular Biology|July 28, 2025
Hyaluronan Ameliorates Viral Pneumonia in Mice and Humans by Inhibiting E2F1 Transcription FactorVandy P Stober, Carol S Trempus, Flavia Galdi, et al.Journal of Medicinal Chemistry|October 2, 2014
Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistance mutations that spares the wild type form of the receptorM Raymond V Finlay, Mark Anderton, Susan Ashton, et al.Pageof 100